JP2009126830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009126830A5 JP2009126830A5 JP2007303850A JP2007303850A JP2009126830A5 JP 2009126830 A5 JP2009126830 A5 JP 2009126830A5 JP 2007303850 A JP2007303850 A JP 2007303850A JP 2007303850 A JP2007303850 A JP 2007303850A JP 2009126830 A5 JP2009126830 A5 JP 2009126830A5
- Authority
- JP
- Japan
- Prior art keywords
- valine
- leucine
- active ingredients
- isoleucine
- antidepressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960000310 ISOLEUCINE Drugs 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- 230000001430 anti-depressive Effects 0.000 claims description 2
- 230000003262 anti-osteoporosis Effects 0.000 claims description 2
- 230000002180 anti-stress Effects 0.000 claims description 2
- 239000000935 antidepressant agent Substances 0.000 claims description 2
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007303850A JP2009126830A (ja) | 2007-11-26 | 2007-11-26 | 治療剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007303850A JP2009126830A (ja) | 2007-11-26 | 2007-11-26 | 治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009126830A JP2009126830A (ja) | 2009-06-11 |
JP2009126830A5 true JP2009126830A5 (zh) | 2011-01-20 |
Family
ID=40818108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007303850A Pending JP2009126830A (ja) | 2007-11-26 | 2007-11-26 | 治療剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2009126830A (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6119969B2 (ja) * | 2013-01-25 | 2017-04-26 | 味の素株式会社 | 血圧降下用アミノ酸含有組成物 |
CN109689039B (zh) * | 2016-09-09 | 2021-09-21 | 味之素株式会社 | 用于预防或改善痴呆症或抑郁状态的组合物 |
CN108042634A (zh) * | 2018-01-24 | 2018-05-18 | 江苏神华药业有限公司 | 一种具有解酒护肝作用的组合物及其制备方法 |
-
2007
- 2007-11-26 JP JP2007303850A patent/JP2009126830A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2011506530A5 (zh) | ||
BRPI0816345A2 (pt) | Formas sólidas de n-[2,4-bis-(1,1-dimetiletil)-5-hidroxifenil]-1,4-diidro-4-o xoquinolin-3-carboxamida | |
CL2007003879A1 (es) | Compuestos derivados de aril-carboxamida; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alzheimer, epilepsia y parkinson. | |
BRPI0909030A2 (pt) | composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. | |
DK2464337T4 (da) | Tabletformulering af N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid til anvendelse til behandling af cystisk fibrose | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
JP2009504909A5 (zh) | ||
TW200942524A (en) | Novel aminomethyl benzene derivatives | |
JP2008542528A5 (zh) | ||
CL2007001917A1 (es) | Compuestos derivados de azaindol espirociclicos; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del dolor, condiciones de panico, depresion, mal de alzheimer, migrana, entre otras. | |
IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
CL2007003190A1 (es) | Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras. | |
JP2008024962A5 (zh) | ||
WO2009125409A3 (en) | Fatty acid amides and uses thereof | |
JP2009126830A5 (zh) | ||
JP2009509934A5 (zh) | ||
JP2009001575A5 (zh) | ||
JP2011125841A5 (zh) | ||
JP2009292763A5 (zh) | ||
WO2010129788A3 (en) | Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders | |
JP2011008097A5 (zh) | ||
JP2008143899A5 (zh) | ||
WO2011058572A3 (en) | Solid dapoxetine | |
JP2010090042A5 (zh) | ||
TH92434B (th) | เก้าอี้ |